While data from a RCT controls for many of the potential confounding factors, using data from non-primary endpoints requires caveats
Common, usually mild: Injection-site reactions (redness, swelling, itching), most frequent with both Mild headache, dizziness, or flushing after injection Initial water retention as IGF-1 rises Transient fatigue in the first 12 weeks Less common, dose-dependent: Carpal tunnel-like wrist symptoms (sign IGF-1 may be too high) Joint discomfort or stiffness Numbness or tingling in extremities Elevated blood glucose (GH antagonizes insulin) The monitoring that matters:IGF-1 (insulin-like growth factor 1, the downstream marker of GH activity) is the lab value that tells you whether youre in a therapeutic range or pushing past it
Although this approach is still in its infancy in Germany (Kckler and Geene 2022), there is an increasing focus on providing the population with healthcare infrastructure close to home and in line with their needs as a task of public services of general interest (ARL 2023, p.14)
Unless advertised, most peptides are for research use only
Semaglutide (Ozempic/Wegovy): Brand name retail: $936-1,349 monthly Compounded semaglutide: $300-500 monthly Budget telehealth programs: $199-350 monthly Tirzepatide (Mounjaro/Zepbound): Brand name retail: $1,023-1,200 monthly Compounded tirzepatide: $400-600 monthly The semaglutide vs tirzepatide comparison covers effectiveness differences
Therefore, serum B 12 values above the cut-off point of deficiency do not necessarily confirm adequate B 12 status
